In this issue:
Application of the 2017 revised McDonald criteria for patients with CIS
Inflammation and disability accrual in progressive-onset MS
Use of newer DMTs in paediatric MS
BMI is associated with brain volume change in MS
Early diagnosis of PML
Long-term effectiveness of DMTs in MS
Characterisation of benign MS
Vitamin D for the treatment of MS
Effectiveness of dimethyl fumarate vs interferon, glatiramer acetate, teriflunomide, or fingolimod
Mobility measures following MS rehabilitation
Please login below to download this issue (PDF)